Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

Statins Are Cost-effective in the Elderly

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

News Daily News

PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives

Michael O'Riordan

August 02, 2024

Think You Need a Statin? AHA’s Risk Calculator May Disagree

News Daily News

Think You Need a Statin? AHA’s Risk Calculator May Disagree

Michael O'Riordan

June 28, 2024

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

News Daily News

Excess ApoB Linked to Increased MI, ASCVD Risk in Adults

Michael O'Riordan

June 04, 2024

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

Statins Effective For Primary Prevention in Old and Very Old

News Daily News

Statins Effective For Primary Prevention in Old and Very Old

Michael O'Riordan

May 29, 2024

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

News Daily News

Very Elderly Benefit From High-Intensity Lipid-Lowering After Acute MI

Michael O'Riordan

May 02, 2024

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.